Morgan Jess S & CO Inc Checkpoint Therapeutics, Inc. Transaction History

Morgan Jess S & CO Inc

  • $115 Million
  • Q3 2022

A detailed history of Morgan Jess S & CO Inc transactions in Checkpoint Therapeutics, Inc. stock. As of the latest transaction made, Morgan Jess S & CO Inc holds 1,894,694 shares of CKPT stock, worth $4.04 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
1,894,694
Previous 1,137,322 66.59%
Holding current value
$4.04 Million
Previous $1.17 Million 68.23%
% of portfolio
1.71%
Previous 1.21%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 21, 2022
BUY
$1.02 - $1.47 $772,519 - $1.11 Million
757,372 Added 66.59%
1,894,694 $1.97 Million
Q2 2022

Jul 18, 2022
BUY
$0.97 - $1.77 $41,329 - $75,416
42,608 Added 3.89%
1,137,322 $1.17 Million
Q1 2022

May 16, 2022
SELL
$1.53 - $3.25 $124,110 - $263,633
-81,118 Reduced 6.9%
1,094,714 $1.94 Million
Q4 2021

Jan 27, 2022
BUY
$2.68 - $4.46 $22,780 - $37,910
8,500 Added 0.73%
1,175,832 $3.66 Million
Q3 2021

Nov 09, 2021
BUY
$2.5 - $3.53 $103,875 - $146,671
41,550 Added 3.69%
1,167,332 $3.85 Million
Q2 2021

Nov 30, 2021
BUY
$2.36 - $3.2 $1.25 Million - $1.7 Million
530,082 Added 88.98%
1,125,782 $3.32 Million
Q1 2021

Nov 30, 2021
BUY
$2.6 - $4.16 $1.55 Million - $2.48 Million
595,700 New
595,700 $1.87 Million

Others Institutions Holding CKPT

# of Institutions
3
Shares Held
1.91M
Call Options Held
0
Put Options Held
0
View Full List

About Checkpoint Therapeutics, Inc.

CKPT Quotes by TradingView
  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $182M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Morgan Jess S & CO Inc Portfolio

Follow Morgan Jess S & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Jess S & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Jess S & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email